Porcine Acute Liver Failure Model Established by Two-phase Surgery and Treated with Hollow Fiber Bioartificial Liver Support System

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2005 Oct 14

PMID 16222738

Citations 5

Authors

Yi Gao

Ning Mu

Xiao-Ping Xu

Yan Wang

Affiliations

Soon will be listed here.

Abstract

Aim: To establish a highly reproducible animal model of acute liver failure (ALF), for assessing the effect of bioartificial liver support system (BALSS).

Methods: A two-phase complete liver devascularization procedure was performed in eight loco-hybrid pigs. Blood biochemical index and liver biopsy were studied every 2 h after surgery, and survival time was recorded. The BALSS constructed with high volume recirculating technique was a hollow fiber circulating system consisting of a hepatocyte reactor-hollow fiber module inoculated with microcarrier-adhering hepatocytes, and a double pump, heparinized, thermostabilized, micro-capsulized activated carbon-adsorbing plasmapheresis system. Twelve pigs undergoing two-phase surgery were randomized into: control group (perfused without hepatocytes, n = 6) and treatment group (perfused with hepatocytes, n = 6). Intergroup liver biochemical indexes, survival time, and liver pathological changes were analyzed at regular intervals.

Results: Two-phase surgery was performed in all the experimental pigs, and there was no obvious difference between their biochemical indexes. After 3 h of phase II surgery, ammonia (Amm) increased to (269+/-37) micromol/L. After 5 h of the surgery, fibrinogen (Fib) decreased to (1.5+/-0.2) g/L. After 7 h of the surgery, ALT, AST, Tbil and PT were (7.6+/-1.8) nka/L, (40+/-5) nka/L, (55+/-8) micromol/L and (17.5+/-1.7) nka/L respectively. After 9 h of surgery, ALB and Cr were (27+/-4) g/L and (87+/-9) micromol/L. After 13 h of surgery, BUN was (3.5+/-0.9) micromol/L. All the above values were different from those determined before surgery. Survival time of pigs averaged 13.5+/-1.4 h. ALF pigs in the other group were treated with BALSS. The comparison analysis between the treated and control animals showed the changes of Tbil, PT, Alb, BUN, Cr, Fib, and Amm (P<0.01), but there was no change of ALT and AST. The survival time was statistically different (P<0.01), and there was no significant difference in histological changes.

Conclusion: The porcine ALF model established by two-phase devascularized surgery is valid and reproducible. The hollow fiber BALSS can meet the needs of life support and is effective in treating ALF.

Citing Articles

The multifaceted role of macrophages during acute liver injury.

Hassan G, Flores Molina M, Shoukry N Front Immunol. 2023; 14:1237042.

PMID: 37736102 PMC: 10510203. DOI: 10.3389/fimmu.2023.1237042.

Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Jin Y, Wang H, Yi K, Lv S, Hu H, Li M Nanomicro Lett. 2021; 13(1):25.

PMID: 34138224 PMC: 8187515. DOI: 10.1007/s40820-020-00550-x.

Establishment of a Novel Simplified Surgical Model of Acute Liver Failure in the Cynomolgus Monkey.

Cai L, Weng J, Feng L, He G, Qin J, Zhang Z Biomed Res Int. 2017; 2016:3518989.

PMID: 28097130 PMC: 5209601. DOI: 10.1155/2016/3518989.

Dynamic tracking of stem cells in an acute liver failure model.

Ezzat T, Dhar D, Malago M, Olde Damink S World J Gastroenterol. 2012; 18(6):507-16.

PMID: 22363116 PMC: 3280395. DOI: 10.3748/wjg.v18.i6.507.

An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.

Tunon M, Alvarez M, Culebras J, Gonzalez-Gallego J World J Gastroenterol. 2009; 15(25):3086-98.

PMID: 19575487 PMC: 2705730. DOI: 10.3748/wjg.15.3086.

References

Demetriou A, WHITING J, Feldman D, LEVENSON S, CHOWDHURY N, Moscioni A . Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science. 1986; 233(4769):1190-2. DOI: 10.1126/science.2426782. View

Rivera D, Gores G, Misra S, Hardin J, Nyberg S . Apoptosis by gel-entrapped hepatocytes in a bioartificial liver. Transplant Proc. 1999; 31(1-2):671-3. DOI: 10.1016/s0041-1345(98)01743-6. View

Aranda E, Sorio L, Quero Z, Martinez A, Vegas A, Zerpa M . Xenotransplantation of isolated encapsulated porcine hepatocytes in the treatment of a highly fulminant hepatic failure model. Transplant Proc. 1997; 29(1-2):920-2. DOI: 10.1016/s0041-1345(96)00234-5. View

Flendrig L, Chamuleau R, Maas M, Daalhuisen J, Hasset B, Kilty C . Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol. 1999; 30(2):311-20. DOI: 10.1016/s0168-8278(99)80078-6. View

Yin C, Chia S, Quek C, Yu H, Zhuo R, Leong K . Microcapsules with improved mechanical stability for hepatocyte culture. Biomaterials. 2003; 24(10):1771-80. DOI: 10.1016/s0142-9612(02)00580-x. View

Chung Y, Lee H, Koh Y, Kim S, Kim S, Choi S . [Isolation and culture of pig hepatocyte in large scale for the application of bioartificial liver system]. Taehan Kan Hakhoe Chi. 2002; 8(3):249-55. View

Patzer 2nd J, Mazariegos G, Lopez R, Molmenti E, Gerber D, Riddervold F . Novel bioartificial liver support system: preclinical evaluation. Ann N Y Acad Sci. 1999; 875:340-52. DOI: 10.1111/j.1749-6632.1999.tb08516.x. View

Naka S, Takeshita K, Yamamoto T, Tani T, Kodama M . Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model. Artif Organs. 1999; 23(9):822-8. DOI: 10.1046/j.1525-1594.1999.06323.x. View

Tsiaoussis J, Newsome P, Nelson L, Hayes P, Plevris J . Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl. 2001; 7(1):2-10. DOI: 10.1053/jlts.2001.20845. View

10.

Ryska M, Kieslichova E, Pantoflicek T, Ryska O, Zazula R, Skibova J . Devascularization surgical model of acute liver failure in minipigs. Eur Surg Res. 2004; 36(3):179-84. DOI: 10.1159/000077261. View

11.

Rozga J, Holzman M, Ro M, Griffin D, Neuzil D, Giorgio T . Development of a hybrid bioartificial liver. Ann Surg. 1993; 217(5):502-9; discussion 509-11. PMC: 1242831. DOI: 10.1097/00000658-199305010-00010. View

12.

Morsiani E, Pazzi P, Moscioni A, Rozga J, Azzena G, Demetriou A . In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation. J Surg Res. 1998; 79(1):54-60. DOI: 10.1006/jsre.1998.5356. View

13.

Dixit V, Gitnick G . The bioartificial liver: state-of-the-art. Eur J Surg Suppl. 1999; (582):71-6. DOI: 10.1080/11024159850191481. View

14.

Maddrey W . Bioartificial liver in the treatment of hepatic failure. Liver Transpl. 2000; 6(4 Suppl 1):S27-30. DOI: 10.1002/lt.500060507. View

15.

Hay P, Veitch A, Smith M, Cousins R, Gaylor J . Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver. Artif Organs. 2000; 24(4):278-88. DOI: 10.1046/j.1525-1594.2000.06499.x. View

16.

Nyberg S, Hay E, Ramin K, Rosen C . Successful pregnancy after porcine bioartificial liver treatment and liver transplantation for fulminant hepatic failure. Liver Transpl. 2002; 8(2):169-70. DOI: 10.1053/jlts.2002.30593. View

17.

Baquerizo A, Mhoyan A, Kearns-Jonker M, Arnaout W, Shackleton C, Busuttil R . Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation. 1999; 67(1):5-18. DOI: 10.1097/00007890-199901150-00003. View

18.

Seglen P . Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res. 1973; 82(2):391-8. DOI: 10.1016/0014-4827(73)90357-1. View

19.

Werner A, Duvar S, Muthing J, Buntemeyer H, Lunsdorf H, Strauss M . Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol Bioeng. 2000; 68(1):59-70. DOI: 10.1002/(sici)1097-0290(20000405)68:1<59::aid-bit7>3.0.co;2-n. View

20.

Suh K, Lilja H, Kamohara Y, Eguchi S, Arkadopoulos N, Neuman T . Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res. 1999; 85(2):243-50. DOI: 10.1006/jsre.1999.5669. View